Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV-Related Oropharyngeal Cancer.
Laila A GharzaiNicholas BurgerPin LiElizabeth M JaworskiCaitlin HendersonMatthew SpectorAndy RoskoMichelle M ChenMark E PrinceCarol R BradfordKelly M MalloyChaz L StuckenPaul SwiecickiFrancis WordenMatthew J SchipperCaitlin A SchonewolfJennifer ShahReshma JagsiSteve ChinnAndrew ShumanKeith CasperMichelle L MierzwaPublished in: The oncologist (2021)
The number of patients with HPV-related oropharyngeal cancers is increasing, and numerous clinical trials are investigating novel approaches to treating these good-prognosis patients. There has been limited work assessing optimal surveillance paradigms in these patients. Patients experience significant appointment-related burdens and have concerns such as physical and mental quality of life. Additionally, patients with early stage HPV-related oropharyngeal cancers express interest in altered surveillance approaches that decrease in-person clinic visits. Optimization of surveillance paradigms to promote broader survivorship care in clinical practice is needed.
Keyphrases
- early stage
- end stage renal disease
- ejection fraction
- newly diagnosed
- clinical trial
- chronic kidney disease
- prognostic factors
- healthcare
- primary care
- clinical practice
- mental health
- physical activity
- squamous cell carcinoma
- patient reported outcomes
- radiation therapy
- case report
- drug induced
- pain management
- cervical cancer screening